Jason Liebowitz is a Rheumatology/Immunology physician affiliated with Columbia University Irving Medical Center. OpenAlex indexes 33 publications with 488 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
161 Fort Washington Ave
New York, NY 100323729
Telephone
212-305-4308Provider last certified this registry record 15 Dec 2022.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Fresenius Kabi USA, LLCProgram year20251 payment
- GlaxoSmithKline, LLC.Program year202410 payments
- Novartis Pharmaceuticals CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
45.4%Folate Analog Metabolic Inhibitor14.9%Methotrexate100%Part D≥58 patientsTNF inhibitor14.2%Humira(Cf) Pen58%Enbrel Sureclick34%Humira8%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
18.3%Corticosteroid12%Prednisone100%Part D≥44 patientsAntidiarrheal microorganisms5%Folic Acid100%Part D≥22 patients+ 1 more class in this area
Musculoskeletal
14.5%Xanthine oxidase inhibitor8.2%Allopurinol100%Part D≥34 patientsNonsteroidal Anti-inflammatory Drug4.4%Diclofenac Sodium100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-CVTC-10269-ACC FROM CONSTRICTION TO RECOVERY: CASE SERIES OF TRANSIENT CONSTRICTIVE PERICARDITIS TREATED WITH INTERLEUKIN-1 INHIBITION
Journal of the American College of Cardiology
2026 - Large Language Models Are Not Role Models: A Meditation on Master Clinicians
The American Journal of Medicine
2025 - The Present and Future of Genetic Sequencing as Applied to Diagnosis and Management in Rheumatology
Arthritis & Rheumatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Rebecca Hahn, MD
Columbia University Irving Medical Center
Susheel Kodali, MD
Columbia University Irving Medical Center
Ronald Wapner, MD
Columbia University Irving Medical Center
Lawrence Honig, MD
Columbia University Irving Medical Center
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”